Latest filing published 09 Jul 2025 for 메타바이오메드.
한국증권금융: trading record in brief
This profile gathers the share dealings of 한국증권금융 in 메타바이오메드. In total, 7 filings cover trades dated from 22 May 2023 to 30 May 2025.
The open-market side counts 6 purchases alongside 1 sale. The totals do not cover 7 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and no sales.
None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 9 July 2025 with an open-market purchase in 메타바이오메드. Typically, a trade is published a median of 48 days after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 한국증권금융
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 298,627 sharesKRXDART:20231010000296Canonical exit: 8 Jan 2024 (T+90)
- 298,627 sharesKRXDART:20230710000303Canonical exit: 8 Oct 2023 (T+90)
- 298,627 sharesKRXDART:20230706000124Canonical exit: 4 Oct 2023 (T+90)
- 298,627 sharesKRXDART:20230612000381Canonical exit: 10 Sept 2023 (T+90)
7 of 7 declarations